Submitted by Sheldon Rampton on
Psychiatrist Frederick K. Goodwin, who hosts a popular show on National Public Radio called "The Infinite Mind," earned "at least $1.3 million from 2000 to 2007 giving marketing lectures for drugmakers, income not mentioned on the program," reports Gardiner Harris.
Cholesterol-reducing drugs called statins have been in the news lately following the release of a major medical study that found that statins can prevent heart disease and stroke in people with no previous history of heart disease.
Statins are among the biggest-selling family of drugs of all time. Many articles about the study mentioned above, including one on the credible web site WebMD, also mention the specific drug used in the study: Crestor.
The study has generated hundreds of articles, most of which repeat the same basic framing of the issue: if heart disease is the problem, a drug is the answer.
Submitted by Diane Farsetta on
A $13.2 million ad campaign thanks 28 members of Congress, 25 of whom are Democrats, "for supporting a children's health-care bill vetoed twice by President George W. Bush in 2007." The ads are by America's Agenda: Health Care for Kids, a new non-profit group whose sole funder is the Pharmaceutical Research and Manufacturers of America (PhRMA).
Submitted by Diane Farsetta on
Submitted by Sheldon Rampton on
Medical research conflicts of interest are in the news lately, thanks to recent congressional hearings by Senator Charles Grassley. But are journalists part of the problem?
Submitted by Bob Burton on
The National Institute for Clinical Excellence (NICE), a UK government agency charged with deciding whether drugs should be subsidized by the British government, has been criticized by some patient groups for refusing to approve new and expensive drugs.
Submitted by Diane Farsetta on
The pharmaceutical company Eli Lilly has announced that it will begin reporting its payments to doctors in late 2009, using an online database. But the disclosure is limited to payments of more than $500 made for giving talks or advice to the company; payments for other services or gifts will not be included. Payments made before 2009 will also not be disclosed.
Submitted by Diane Farsetta on
To develop its new website that tries to help the public understand direct-to-consumer drug ads, the U.S.
Submitted by Diane Farsetta on
According to a recent Gallup poll, the public has "a dimmer view of the pharmaceutical industry than they do of the advertising / public relations sector, if you can imagine such a thing," writes Mark Dolliver.
Submitted by Diane Farsetta on
Pfizer's getting ready to resume advertising for its cholesterol drug Lipitor. In February, the drugmaker pulled its Lipitor ads, over charges they were misleading.
Center for Media and Democracy (CMD)
520 University Ave, Ste 305 • Madison, WI 53703 • (608) 260-9713
CMD is a 501(c)(3) tax-exempt non-profit.
© 1993-2024